Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes

被引:10
|
作者
Rosta, Valentina [1 ]
Trentini, Alessandro [1 ]
Passaro, Angelina [2 ]
Zuliani, Giovanni [2 ]
Sanz, Juana Maria [2 ]
Bosi, Cristina [2 ]
Bonaccorsi, Gloria [2 ,3 ,4 ]
Bellini, Tiziana [1 ,4 ]
Cervellati, Carlo [2 ]
机构
[1] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Sect Med Biochem Mol Biol & Genet, I-44121 Ferrara, Italy
[2] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44121 Ferrara, Italy
[3] Univ Ferrara, Menopause & Osteoporosis Ctr, I-44124 Ferrara, Italy
[4] Univ Ferrara, Ctr Gender Med, I-44121 Ferrara, Italy
关键词
sex difference; paraoxonase-1; type-2; diabetes; oxidative stress; inflammation; HIGH-DENSITY-LIPOPROTEIN; GENDER-DIFFERENCES; OXIDATIVE STRESS; HDL; SERUM; COMPLICATIONS; ANTIOXIDANT; RISK; ASSOCIATIONS; ARYLESTERASE;
D O I
10.3390/antiox9080683
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type-2 diabetes (T2D) and its cardiovascular complications are related to sex. Increasing evidence suggests that paraoxonase 1 (PON1) activity, an antioxidant enzyme bound to high-density lipoproteins (HDL), is implicated in the onset and clinical progression of T2D. Since we previously showed that PON1 is a sexual dimorphic protein, we now investigated whether sex might impact the relationship between PON1 and this chronic disease. To address this aim, we assessed PON1 activity in the sera of 778 patients, including controls (women, n = 383; men, n = 198) and diabetics (women, n = 79; men = 118). PON1 activity decreased in both women and men with T2D compared with controls (p< 0.05 andp> 0.001, respectively), but the change was 50% larger in the female cohort. In line with this result, the enzyme activity was associated with serum glucose level only in women (r = -0.160,p= 0.002). Notably, only within this gender category, lower PON1 activity was independently associated with increased odds of being diabetic (odds ratio (95% Confidence interval: 2.162 (1.075-5.678)). In conclusion, our study suggests that PON1-deficiency in T2D is a gender-specific phenomenon, with women being more affected than men. This could contribute to the partial loss of female cardiovascular advantage associated with T2D.
引用
收藏
页码:1 / 12
页数:11
相关论文
共 50 条
  • [1] Paraoxonase-1 (PON1) in retinal physiology and pathophysiology
    Oczos, Jadwiga
    Kloeckener-Gruissem, Barbara
    Berger, Wolfgang
    Grimm, Christian
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] DETECTION OF PARAOXONASE-1 (PON1) IN SEMINAL PLASMA
    Marsillach, Judit
    Lafuente, Rafael
    Lopez, Gemma
    Camps, Jordi
    Joven, Jorge
    Checa, Miguel A.
    Brassesco, Mario
    [J]. JOURNAL OF ANDROLOGY, 2009, 30 : 107 - 108
  • [3] Relationship between the esterase paraoxonase-1 (PON1) and metal concentrations in the whole blood of Inuit in Canada
    Laird, Brian D.
    Goncharov, Alexey B.
    Ayotte, Pierre
    Chan, Hing Man
    [J]. CHEMOSPHERE, 2015, 120 : 479 - 485
  • [4] Analysis of paraoxonase-1 (PON1) gene polymorphisms in vitiligo
    Seckin, Havva Yildiz
    Kalkan, Goknur
    Benli, Ismail
    Butun, Ilknur
    Bas, Yalcin
    Takci, Zennure
    Karakus, Nevin
    [J]. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2015, 40 (05): : 356 - 362
  • [5] Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides
    Lopez-Flores, I.
    Lacasana, M.
    Blanco-Munoz, J.
    Aguilar-Garduno, C.
    Sanchez-Villegas, P.
    Perez-Mendez, O. A.
    Gamboa-Avila, R.
    [J]. TOXICOLOGY LETTERS, 2009, 188 (02) : 84 - 90
  • [6] Paraoxonase 1 mass (PON1) and microvascular complications in type 2 diabetes (DM)
    Hanley, Anthony J.
    Zinman, Bernard
    Maguire, Graham
    Mamakeesick, Mary
    Harris, Stewart B.
    Hegele, Robert
    Retnakaran, Ravi
    Klein, Ronald
    Connelly, Phillip W.
    [J]. DIABETES, 2007, 56 : A213 - A213
  • [7] THE HUMAN PARAOXONASE-1 (PON1) PHENOTYPE MODIFIES THE EFFECT OF STATINS ON PON1 ACTIVITY AND LIPID PARAMETERS
    Paragh, G.
    Mirdamadi, H.
    Harangi, M.
    Sztanek, F.
    Derdak, Z.
    Kassai, A.
    Seres, I.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [8] Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
    Mackness, Bharti
    Turkie, Wajdi
    Mackness, Mike
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 8 - 13
  • [9] Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners?
    Davis, Kimberly A.
    Crow, J. Allen
    Chambers, Howard W.
    Meek, Edward C.
    Chambers, Janice E.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (08) : 1226 - 1231
  • [10] Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel
    Dery, Jean-Pierre P.
    Khalil, Abdelouahed
    Dery, Ugo
    Roy, Melanie
    Tricoci, Pierluigi
    Becker, Richard
    Rinfret, Stephane
    Larose, Eric
    Barbeau, Gerald
    DeLarochelliere, Rober
    Rodes-Cabau, Josep
    Bertrand, Olivier F.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B40 - B40